Actively Recruiting
Epstein-Barr Virus and Cancer Risks
Led by Sun Yat-sen University · Updated on 2024-01-12
100000
Participants Needed
2
Research Sites
1169 weeks
Total Duration
On this page
Sponsors
S
Sun Yat-sen University
Lead Sponsor
W
Wuzhou Red Cross Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this prospective cohort study is to investigate the associations between Epstein-Barr Virus (EBV) antibody levels and the risk of overall and site-specific cancer types in Southern China. The main questions it aims to answer are: Question 1: In addition to the established EBV-associated cancer types, such as lymphomas, nasopharyngeal carcinoma, and stomach cancer, whether EBV is associated with other cancer types? Question 2: What's the cancer burden attributed to EBV in Southern China?
CONDITIONS
Official Title
Epstein-Barr Virus and Cancer Risks
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Residents of Zhongshan or Wuzhou City
- No medical history of cancer
- Physically healthy, mentally alert, and willing to cooperate with follow-up procedures
You will not qualify if you...
- Serious cardiovascular, liver, or kidney disease
- Current diagnosis of cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Zhongshan People's Hospital
Zhongshan, Guangdong, China, 528403
Actively Recruiting
2
Wuzhou Red Cross Hospital
Wuzhou, Guangxi, China, 543002
Actively Recruiting
Research Team
W
Wei-Hua Jia
CONTACT
Y
Yong-Qiao He
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here